Fluid intelligence in an older COPD sample following short- or long-term exercise by Etnier, Jennifer L. & NC DOCKS at The University of North Carolina at Greensboro
Fluid intelligence in an older COPD sample following short- or long-term exercise 
 
By: Jennifer L. Etnier and Michael Berry 
 
This is a non-final version of an article published in final form in 
 
Etnier, J.L., & Berry, M.J. (2001). Fluid intelligence in an older COPD sample following short- 
or long-term exercise.  Medicine and Science in Sport and Exercise, 33 (10), 1620-1628. 
https://doi.org/10.1097/00005768-200110000-00002 
 
***© 2001 American College of Sports Medicine. Reprinted with permission. No further 
reproduction is authorized without written permission from Lippincott, Williams & 
Wilkins. This version of the document is not the version of record. Figures and/or pictures 
may be missing from this format of the document. *** 
 
Abstract: 
 
Purpose: Research supports an association between aerobic fitness and cognitive functioning in 
chronic obstructive pulmonary disease (COPD) patients. However, the impact of exercise 
intervention duration has not been satisfactorily examined. Therefore, the purpose of this study 
was to examine the effects of a 3-month and an 18-month exercise intervention on the cognitive 
functioning of an older COPD sample. Methods: COPD patients (56–80 yr) were given a 3-
month exercise program and then were randomly assigned to continue for an additional 15 
months (long-term group) or to leave the exercise program (short-term group). Age and 
education were assessed before involvement in the exercise intervention (baseline). Fluid 
intelligence, pulmonary function, aerobic fitness, and depression were assessed at baseline, at 3 
months, and at 18 months. Results: After 3 months of exercise, results indicated that cognitive 
function and walk distance improved significantly. Results also indicated that the gain in 
cognitive function was reliably predicted by the decrease in V̇E at V̇O2peak. At 18 months, results 
indicated that cognitive performance did not differ between the short- and long-term exercise 
groups, but that walk distance improved significantly for the long-term group, but not for the 
short-term group. Results of a regression analysis showed that the cognitive performance 
improvement from 3 months to 18 months was predicted by the gain in walk distance and by the 
decrease in V̇E at V̇O2peak. Conclusion: It is concluded that improvements in aerobic fitness are 
associated with gains in fluid intelligence after 3 and 18 months of exercise training in COPD 
patients. However, at 18 months, exercise group was not predictive of the gains in cognitive 
performance. Therefore, a 3-month exercise program may be a sufficient impetus to foster these 
cognitive gains in COPD patients. 
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Article: 
 
Aging involves more than the simple advancing of chronologic age; it also involves the initial 
development and eventual decline of the body across the lifespan, and in many older adults it is 
associated with concomitant changes in cognition. Aerobic capacity is one of the physical 
parameters that shows an age-related decline in older years. Aerobic capacity peaks in the late 
teens or early twenties and declines at the rate of approximately 0.45 mL·kg−1·min−1 each year 
thereafter (23,27). Cognitive functioning typically exhibits an age-related decline (3,25,37). 
Although older adults are able to maintain their performance capacity on crystallized intelligence 
tasks (25,37), research evidence has shown that as people age beyond 60 yr, most show a pattern of 
decline in the ability to perform tasks that require problem solving (10,11), assess fluid 
intelligence (24,40), or have a large emphasis on speed of performance (26). 
 
These coinciding declines in aerobic fitness and cognition have led researchers to contemplate 
the possibility of a relationship between these systems (13,14). Cross-sectional studies in which fit 
older people have been compared to unfit older people generally support the notion of an 
association between physical fitness and the cognitive parameters that experience age-related 
declines (7,8,15,21,26,34). However, longitudinal studies in which fitness has been manipulated in 
older people have produced mixed results. Positive support for a relationship between fitness 
and cognition has been found in some studies (13,14,17), but not in others (4,32). Thus, the research as 
a whole suggests that the maintenance of fitness is associated with improved cognitive 
performance, but the efficacy of an exercise intervention for improving cognitive performance 
has not been clearly established. 
 
Individuals with chronic obstructive pulmonary disease (COPD) are frequently hypoxemic and 
deconditioned. These individuals exhibit a rapid decline in functional aerobic capacity because 
of ventilatory limitations and a sedentary lifestyle. Additionally, COPD patients typically display 
declines in a number of cognitive functions, such as memory (9,35), abstract reasoning skills (35), 
and reaction time (9,35). However, as with normal older adults, aerobic fitness levels of COPD 
patients have been found to be positively related to cognitive functioning (20), and exercise 
training in COPD patients has been shown to be associated with improvements in cognitive 
parameters (16,18,19). 
 
Previous investigations into the effects of exercise on cognition in COPD patients have only 
examined the efficacy of short-term exercise interventions. For example, Emery (16) and Emery et 
al. (18) report data from the same study, which involved a 30-d exercise intervention, and Emery 
et al. (19) reported results from a 10-wk exercise intervention. Of obvious interest are the further 
benefits that might be realized from a longer exercise intervention. The primary focus of this 
investigation was to examine the effects of formal and structured outpatient exercise programs of 
different lengths on fitness and cognition in a sample of COPD patients. It was hypothesized that 
after a short-term formal exercise intervention, all participants would display an improvement in 
fitness measures and in cognitive measures. Continued improvement was expected in those 
participants randomly assigned to remain in the formal exercise intervention (long-term group) 
and subsequent maintenance or declines in aerobic fitness and cognition were expected in those 
participants randomized to leave the formal exercise intervention (short-term group). It was 
further hypothesized that cognitive function at baseline would be predicted by measures of age 
and aerobic fitness and that gains in cognitive function at 3 months and at 18 months would be 
predicted by age and by gains in aerobic fitness. 
 
METHODS 
 
Participants 
 
Participants were individuals from the Reconditioning Exercise And COPD Trial (REACT) who 
agreed to participate in cognitive testing for the duration of the study. For the REACT study, the 
Claude Pepper Older Americans Independence Center of the Wake Forest University School of 
Medicine recruitment core solicited older participants (55–80 yr) from the local community 
through physician referral, pamphlet distribution, and advertisements in local newspapers and on 
local television stations. To qualify for the study, all individuals had to display an expiratory 
airflow limitation such that the FEV1.0/FVC ratio was less than or equal to 70% and the 
FEV1.0 was greater than or equal to 20% of predicted values. This expiratory airflow limitation 
could not be reversible by medication. Additionally, inclusion criteria required that participants 
reported difficulties performing various activities of daily living because of shortness of breath 
and had not been participating in a regular exercise or pulmonary rehabilitation program for the 
preceding 6 months. Subjects’ age, sex, and years of education were recorded by self-report. A 
complete list of exclusion criteria is given in Table 1. Subjects were asked not to use inhaled or 
oral bronchodilators within the 4 h preceding testing. 
 
Table 1: Exclusion criteria. 
Criteria Characteristics that Would Result in Exclusion Screening Methods 
Health Active treatment for cancer, severe congestive heart failure, 
stroke, peripheral vascular disease, coronary artery 
disease, valvular heart disease, major psychiatric disease, 
severe anemia, liver or renal disease, uncontrolled 
diabetes or hypertension, orthopedic impairment, 
blindness, or deafness 
History, physical exam, 
graded exercise test, 
personal physician 
COPD with disability FEV1.0/FVC > 70%, FEV1.0 < 20% of predicted or absence 
of reported disability, oxygen desaturation during exercise 
to < 90% at a heart rate < 50% of age-predicted maximum 
without supplemental O2 
Pulmonary function test, 
history, graded exercise test 
Ability to comply with 
exercise interventions 
Inability to perform exercise because of physical disability 
or positive exercise stress test 
History, physical exam, 
graded exercise test 
Alcohol use Consumption (current or within proceeding 2 months) > 2 
drinks•d–1 
History 
Inability to complete 
study 
Living > 50 miles from center or plans to move History 
 
Initially, there were 40 volunteers for the study. Of these, 3 dropped out of the REACT before 
the 3-month session; 8 remained in the study but were unavailable for cognitive testing at both 
the 3-month session and the 18-month session; 29 were tested at baseline and at 3 months; and 
15 were tested at baseline, 3 months, and 18 months. Demographic information and means and 
standard deviations for the baseline data on cognitive performance, aerobic fitness, oxygen 
saturation of hemoglobin (Hb) (SpO2), and pulmonary function for the participants who were 
available for the baseline session and either subsequent session (N = 29) and for those who were 
only available for the baseline testing (N = 11) can be found in Table 2. 
 
Table 2: Demographic, cognitive, aerobic, SpO2, and pulmonary means and standard deviations for study participants. 
Sample/Variable 
Baseline Measures 
for Those Who 
Continued Testing 
after Baseline 
(N = 29) 
Baseline Measures 
for Those Who 
Dropped Out after 
Baseline (N = 11) 
3-Month Measures 
for Those Tested at 
Baseline and at 
3-Months and 
Included in the 
3-Month Analysis 
(N = 29) 
3-Month Measures 
for the Short-Term 
Exercisers Included 
in the 18-Month 
Analysis (N = 7) 
3-Month Measures 
for the Long-Term 
Exercisers Included 
in the 18-Month 
Analysis (N = 8) 
18-Month Measures 
for the Short-Term 
Exercisers Included 
in the 18-Month 
Analysis (N = 7) 
18-Month Measures 
for the Long-Term 
Exercisers Included 
in the 18-Month 
Analysis (N = 8) 
Sex 18 men, 11 women 3 men, 8 women 18 men, 11 women 6 men, 1 woman 5 men, 3 women 6 men, 1 woman 5 men, 3 women 
Age range (yr) 58–80 56–80 Same as baseline 59–79 62–74 59–79 62–74 
Mean age (yr) 68.10 ± 6.03 68.45 ± 7.54 Same as baseline 69.71 ± 6.32 67.13 ± 3.68 69.71 ± 6.32 67.13 ± 3.68 
CESD 9.10 ± 9.17 5.00 ± 3.90 8.48 ± 8.60 5.14 ± 4.14 6.00 ± 8.94 5.43 ± 4.79 6.00 ± 8.85 
CF (number correct) 18.52 ± 6.07 19.64 ± 7.02 23.45 ± 5.44 23.43 ± 4.61 25.63 ± 5.60 23.29 ± 4.86 28.13 ± 4.94 
V̇O2peak (mL•kg-1•min-1) 18.27 ± 3.69 16.86 ± 4.88 19.21 ± 4.19 21.61 ± 3.86 20.69 ± 3.90 19.86 ± 3.60 19.85 ± 4.24 
Walk distance (feet) 1614.02 ± 392.43 1500.64 ± 314.23 1821.31 ± 368.50 1959.71 ± 282.26 2041.50 ± 202.34 1883.86 ± 273.98 2081.88 ± 161.64 
FVC (L) 2.91  ± 0.81 2.83 ± 1.10 2.93 ± 0.79 3.35 ± 0.78 3.06 ± 0.73 3.14 ± 0.83 3.24 ± 0.88 
FEV1.0 (L) 1.69 ± 0.55 1.43 ± 0.46 1.69 ± 0.57 2.04 ± 0.45 1.75 ± 0.62 1.92 ± 0.59 1.81 ± 0.72 
FEV1.0 (% of predicted) 61.41 ± 16.35 58.45 ± 15.03 61.31 ± 17.82 68.43 ± 12.57 61.63 ± 19.42 66.00 ± 15.34 64.13 ± 20.64 
FEV1.0 /FVC 57.83 ± 9.81 52.45 ± 11.70 57.00 ± 10.10 62.00 ± 9.07 56.63 ± 11.21 61.71 ± 11.74 55.25 ± 10.51 
MVV (L•min-1) 110.62 ± 23.57 96.00 ± 23.09 73.21 ± 28.83 90.14 ± 24.11 78.38 ± 33.59 84.15 ± 38.95 76.50 ± 30.30 
SpO2 (%) after GXT 93.76 ± 2.56 92.20 ± 4.05 93.41 ± 2.80 93.43 ± 3.55 93.25 ± 1.83 93.00 ± 3.16 92.50 ± 2.67 
SpO2 (%) after 6-min walk 95.03 ± 2.56 92.73 ± 3.69 94.54 ± 2.59 95.00 ± 3.42 94.00 ± 2.45 93.14 ± 3.53 93.00 ± 2.73 
V̇E (L•min-1) 52.18 ± 14.76 43.54 ± 19.10 54.08 ± 17.51 63.91 ± 15.98 58.27 ± 21.47 60.59 ± 13.86 55.44 ± 14.49 
CESD, Center for Epidemiological Studies Depression Scale; CF, Culture Fair Intelligence Test; V̇O2peak, peak oxygen consumption; FVC, forced vital capacity; 
FEV1.0, forced expiratory volume in 1 s; MVV, maximum voluntary ventilation; SpO2, oxygen saturation of hemoglobin; GXT, graded exercise test; V̇E, 
ventilation at V̇O2peak. 
 
Materials 
 
Pulmonary function data. A body plethysmograph (Medical Graphics model 1085; Medical 
Graphics Corp., Minneapolis, MN) was used to obtain the spirometry and lung volume 
measurements. These measurements were made following the guidelines of the American 
Thoracic Society (1,38). 
 
Medication use. Participants were asked to gather all prescription medicines taken during the 
previous 2 wk and to bring the containers to the testing session. At the testing session, the 
interviewer verified that these were all of the medicines taken in the last 2 wk and recorded the 
medication by name, dose, and regimen. The medications were then classified as being 
respiratory drugs or cardiovascular drugs on the basis of the 49th Edition of the Physicians’ Desk 
Reference(33). The total number of respiratory drugs and of cardiovascular drugs was recorded for 
each participant at each testing session. 
 
Graded exercise test. In conducting the graded exercise tests (GXTs), the modified Naughton 
treadmill protocol and the American College of Sports Medicine termination criteria (31) were 
used. During all GXTs, ventilatory and respiratory gas analysis was performed with a 
cardiopulmonary exercise system (CPX/D; Medical Graphics Corp.). Peak oxygen consumption 
(V̇O2peak) was defined as the highest V̇O2 that occurred during the GXT. Oxygen saturation of 
Hb during the GXT (GXT SpO2) was monitored using a pulse oximeter (Armstrong Medical, 
BCI International, Waukesha, WI) and was defined as the value that occurred at V̇O2peak. Minute 
ventilation (V̇E) was defined as the value attained at V̇O2peak. 
 
6-min walk test. The 6-min walk test has been shown to provide an accurate estimate of 
V̇O2peak when a traditional GXT may be prohibitive (39). All participants were asked to walk a 
measured course for 6 min and to attempt to cover as much distance as possible in the given 
time. Participants walked at a self-selected pace and were advised to decrease their pace or to 
stop walking if perceived symptoms became excessive. No feedback was given throughout the 
test. Just before the end of the 6 min, an exercise technician placed a finger probe on the subject 
so that SpO2 (walk SpO2) could be assessed immediately after the 6-min period. The distance 
covered during the 6 min was assessed in feet (walk distance). In a sample of 43 patients with 
chronic lung disease or chronic heart failure, the correlation between 6-min walk distance and 
time to exhaustion on a maximal exercise test has been reported to be r = 0.58 (22). 
 
Fluid intelligence. Fluid intelligence is defined as culture free performance in abstractions and 
relations, and is differentiated from crystallized intelligence, which is defined as verbal, 
numerical, spatial, and mechanical abilities (25). Fluid intelligence is typically considered to 
represent the abilities of reasoning and problem-solving. To assess fluid intelligence, forms A 
and B of Scale 3 of the Culture Fair (CF) Intelligence Test (Institute for Personality and Ability 
testing (IPAT), Champaign, IL) were administered. Scale 3 was chosen because it was designed 
for use on an educated adult population and thus should not be limited by possible ceiling 
effects. Following the recommendation of the IPAT, form A was administered before form B to 
minimize test reactivity and to ensure that premature test sophistication did not occur. 
 
Each form consists of four different subtests including series (13 items), classifications (14 
items), matrices (13 items), and conditions (10 items). The series test requires participants to 
choose a response that best completes progressive series of figures. The classifications test 
requires participants to identify two figures that are different from three other figures. The 
matrices subtest requires participants to correctly complete a design or matrix that is missing one 
figure. The conditions task requires participants to select a figure that mimics the conditions 
displayed by a dot that is present in the test figure (e.g., the dot is under a diagonal line and 
inside a square). Each subtest is scored by simply counting the number of correct responses (on 
the classifications subtest, both answers must be correct). A composite score is calculated by 
summing the subtest scores. 
 
The recommended time limit for each subtest was doubled. Although this limits our ability to 
make comparisons between these participants and the general population, it was done to reduce 
test anxiety, to maximize the amount of data collected, and to minimize the effects of speed of 
performance on fluid intelligence (2,24). Even-odd split-half reliability coefficients of the test 
range from 0.71–0.92 when administered with the extended time limits (29). Instructions were 
those provided in the manual and were read to participants. An opportunity to ask questions was 
allowed at any point during or immediately after instruction. Breaks and verbal encouragement 
were offered between subsets. 
 
Depression. Research has indicated that depression may impact cognitive performance (28). 
Therefore, the Center for Epidemiological Studies Depression Scale (CESD) was used to assess 
symptoms of depression (36). The CESD is a self-administered questionnaire that consists of 20 
statements regarding a participant’s feelings in the past week (36). Participants ranked the 
statements on a 4-point scale from “rarely or none of the time” to “most or all of the time.” Total 
scores can range from 20–80, with higher scores indicating greater depression. In a sample of 
2846 people randomly selected from the general population, the CESD correlated moderately 
with interviewer ratings of depression (r = 0.49) and with measures of symptoms 
of depression (Lubin, r = 0.51; Bradburn Negative Affect, r = 0.60; Bradburn Balance, r = 
61) (36). In a sample of 35 clinically depressed individuals, the correlation between the CESD and 
another measure of symptoms of depression, the SCL-90, has been reported to be r = 0.83 (36). 
 
Testing 
 
Each time that participants were tested, they were tested on three separate days to minimize 
fatigue. On the first day, participants completed the pulmonary function tests and the CESD. On 
the second day, participants completed the GXT. On the third day, participants completed the CF 
before performing the 6-min walk test. 
 
Exercise Training 
 
Exercise sessions were held Monday, Wednesday, and Friday of each week. The exercise 
training program consisted of walking, upper body strength training, and stretching exercises. 
Exercise was prescribed using ratings of perceived dyspnea (RPD) (5). These ratings were 
described as global ratings of perceived breathlessness and were given on a 1–10 scale. 
Participants were instructed to walk at a RPD of 3–4 (moderate to somewhat hard). Perceived 
symptoms as assessed using the RPD scales, heart rate, and SpO2 measures were taken before 
exercise, 20 min into exercise, and immediately after cool-down. In the event of a low 
SpO2 (≤88%), exercise was suspended and participants returned to exercise after a doctor visit 
and prescription of oxygen. Participants were asked initially to walk approximately double the 
walking time they had completed during their GXT and were encouraged to gradually increase to 
30 min over the course of 3 months. Resistance training was completed immediately after the 
aerobic exercise cool-down and consisted of biceps curls, triceps extension, shoulder flexion, 
shoulder abduction, and shoulder shrugs. Two sets of each exercise were performed, with 15 
repetitions in each set. Initial resistance was determined experimentally during the orientation 
visit for each exercise and was increased as the participants desired. 
 
Procedure 
 
On arrival at the REACT study site, written informed consent forms, which had been approved 
by the university’s institutional review board for research with human subjects, were obtained 
from the participant. During the initial (baseline) testing days, assessments were made for 
pulmonary function, CESD, GXT, CF, and walk distance. Additionally, during baseline 
participants completed a medical health history questionnaire, underwent a medical examination 
to gauge program eligibility, and provided information relative to medication use. Participants 
were scheduled for cognitive testing and were randomly assigned to either be tested on fluid 
intelligence (CF) or to complete computerized tests of inhibition, speed of processing, and 
memory. This procedure was followed because of time constraints and because of the high 
testing burden already being placed on the participants. There were inadequate data obtained 
from the three computerized cognitive measures at 3 months and at 18 months for any 
meaningful analyses to be conducted. Thus, the present report is limited to the CF. 
 
All participants were initially involved in the exercise intervention for 3 months. After 3 months 
of exercise, participants were retested on the pulmonary function tests, medication use, CESD, 
GXT, CF, and walk distance. Participants were then randomized to the long-term group or the 
short-term group. Participants in the long-term group continued the structured exercise program 
for an additional 15 months, whereas participants randomized to the short-term group were 
encouraged to continue exercising; however, no formal structured program was provided. After 
these 15 additional months, participants were again tested (18-month session) on pulmonary 
function, medication use, CESD, GXT, CF, and walk distance. 
 
An important consideration of this study is that a no-exercise control group was not included in 
the study. The REACT study, of which this investigation is a part, was a two-arm randomized 
clinical trial that was designed to compare the effectiveness of a short-term versus a long-term 
exercise intervention in terms of physical function, acute exacerbation of chronic obstructive 
pulmonary disease, health-related quality of life, and cost (12). Thus, since the primary question of 
interest in REACT was to examine the relative benefits of a short-term exercise intervention as 
compared with a long-term exercise intervention, the inclusion of a no-exercise control group 
was not deemed to be necessary. 
 
Statistical Analysis 
 
All analyses were conducted using the Statistical Package for Social Sciences (SPSS) software 
for Windows 95 (version 9.0, SPSS, Inc., Chicago, IL). In general, we were interested in testing 
for changes in the physiological and cognitive variables as a function of involvement in the 
formal exercise program. We were further interested in determining if the changes in cognitive 
function were predicted by age or by changes in measures of aerobic fitness. The number of 
predictors at each session was limited by the sample size available for analyses and, therefore, 
the fullest analysis possible was chosen given the available sample at that time. Additionally, in 
interpreting the results of the regression analyses, it is important to recognize the degree to which 
the expected amount of explained variance could exceed zero when the explained variance in the 
population is actually equal to zero. For the baseline analysis, there are 40 subjects and 6 
predictors and the R2 attributable to chance is 0.13. For the 3-month analysis, there are 29 
subjects and 4 predictors and, therefore, the R2 attributable to chance is 0.11. For the 18-month 
analysis, there are 15 subjects and 5 predictors and the R2 attributable to chance is 0.29. 
 
Because of the decrease in sample size between baseline and 3 months and between 3 months 
and 18 months, one-way analysis of variance (ANOVA) was performed to test for possible 
differences between those individuals who were tested only at baseline (N = 11) and those who 
were tested at baseline and either 3 months or 18 months (N = 29). Differences were tested for 
age, CESD score, and education level and for baseline measures of respiratory drugs, 
cardiovascular drugs, V̇O2peak, V̇E, walk distance, CF, FEV1.0, FVC, FEV1.0/FVC, maximum 
voluntary ventilation (MVV), predicted MVV, and predicted FEV1.0. At baseline, a hierarchical 
regression analysis was applied with CF as the criterion. The predictor variables of CESD and 
education were forced into the model first and then the remaining predictor variables of age and 
the measures of aerobic fitness (V̇O2peak, V̇E, walk distance) were entered stepwise. 
 
At 3 months, repeated measures ANOVAs were used to test for changes in CF, walk distance, 
V̇O2peak, respiratory drugs, cardiovascular drugs, V̇E, walk SpO2, and GXT SpO2 as a function of 
time (baseline, 3 months). Repeated measures MANOVAs were used to test for changes in the 
pulmonary function variables as a function of time (baseline, 3 months). Since all participants 
were involved in exercise from baseline to the 3-month session, examination of the group 
variable was not relevant. Regression analysis was then used to see if the change in CF from 
baseline to 3 months could be predicted by age or by changes in walk distance, V̇O2peak, or 
V̇E from baseline to 3 months. 
 
At 18 months, repeated measures ANOVAs were used to test for changes in CF, walk distance, 
V̇O2peak, respiratory drugs, cardiovascular drugs, V̇E, walk SpO2, and GXT SpO2 as a function of 
time (3 months, 18 months) and group (short-term, long-term). Repeated measures MANOVAs 
were used to test for changes in the pulmonary function variables as a function of time (3 
months, 18 months) and group (short-term, long-term). Regression analysis was then used to 
determine whether changes in CF from 3 months to 18 months could be predicted from age, from 
group, or from changes in walk distance, V̇O2peak, or V̇E from 3 months to 18 months. 
 
When appropriate, the Huynh-Feldt epsilon was used to check the sphericity assumption. When 
the sphericity assumption was not met (i.e., ε < 0.75), multivariate tests of significance were 
used. For all effects, eta-squared (η2) values were reported as an index of the magnitude of the 
effect size. Means and standard deviations for the samples included in the 3-month and 18-month 
analyses can be found in Table 2. A power analysis was conducted using effect size (ES) 
estimates calculated using Cohen’s d and derived from the most similar cognitive parameters 
reported in the literature on cognition and exercise in COPD patients (16,18,19). The ES for the 
within-subjects analysis at 3 months was estimated as 0.34 on the basis of an average of reported 
pre-post changes (16,18,19). Using this effect size and assuming that the correlation between the 
repeated measurements was 0.50, the power for the time effect at 3 months with 29 subjects 
available was estimated to be 0.53 (30). The ES for the between-subjects analysis at 18 months 
was estimated as 0.54 on the basis of the reported differences in cognitive performance between 
treatment and control groups (19). Using this effect size, the power for the group effect at 18 
months with 15 subjects available was estimated to be 0.23 (30). Because of the low power at 
these time points, main effects and interaction effects that were critical to the interpretation of the 
results and that did not reach significance were further examined so that effect sizes could be 
presented. 
 
RESULTS 
 
Participant Demographics 
 
Sample sizes differed at baseline (N = 40), 3 months (N = 29), and 18 months (N = 15) because 
of both the complete departure of participants from the REACT study (N = 3) and the participant 
missing either the 3-month session (N = 8) or the 18-month session (N = 22). No significant 
differences (F values = 0.04–3.47, P values > 0.05) were found on any of the dependent 
variables between those individuals who had sufficient data to be included in the 3-month or 18-
month analysis (N = 29) and those who were omitted from both the 3-month and 18-month 
analyses because of missing data (N = 11). 
 
Before Exercise Intervention (Baseline) 
 
Prediction of CF by CESD, education, age, and aerobic fitness measures. CESD score was 
entered into the regression and explained 14% of the observed variance in CF performance 
(F (1,37) = 6.02, P < 0.02). Education level was also entered into the regression and explained an 
additional 15% of the observed variance in CF performance (Fchange(1,36) = 7.30, P < 0.02). 
Walk distance was stepped into the equation next and added significantly to the prediction of CF 
performance (Fchange(1,35) = 12.62, P < 0.001, r2change = 0.19). Age was stepped into the equation 
next and accounted for a further significant increase in the explained variance in CF performance 
(Fchange(1,34) = 5.40, P < 0.03, r2change = 0.07). Thus, after statistically controlling 
for depression and education level, participants who walked farther during the 6-min walk test 
and were younger in age performed better on the CF test at baseline. 
 
After 3 Months of Exercise Intervention for All 
 
Tests of changes from baseline to 3 months. A significant increase in CF from baseline (mean 
= 18.52, SD = 6.07) to 3 months (mean = 23.45, SD = 5.44) was found (Wilk’s λ = 0.38, F (1,28) 
= 45.09, P < 0.001, η2 = 0.62). Significant increases in walk distance (Wilk’s λ = 0.65, F (1,28) = 
15.40, P < 0.001, η2 = 0.36) from baseline (mean = 1614.03, SD = 392.43) to 3 months (mean = 
1821.31, SD = 368.50) and in V̇O2peak (Wilk’s λ = 0.78, F (1,28) = 8.15, P < 0.01, η2 = 0.23) 
from baseline (mean = 18.27, SD = 3.69) to 3 months (mean = 19.21, SD = 4.19) were found. 
 
There was not a significant change in either the total number of respiratory drugs taken (Wilk’s λ 
= 0.96, F (1,27) = 1.00, P > 0.05, η2 = 0.04) or the total number of cardiovascular drugs taken 
(Wilk’s λ = 1.00, F (1,27) = 0.00, P > 0.05, η2 = 0.00). The change in V̇E was not significant 
(Wilk’s λ = 0.93, F (1,27) = 1.93, P > 0.05, η2 = 0.07). There were not significant changes in 
SpO2 walk (Wilk’s λ = 0.91, F (1,27) = 2.72, P > 0.05, η2 = 0.09) or SpO2 GXT (Wilk’s λ = 
0.97, F (1,28) = 0.83, P > 0.05, η2 = 0.03). There also was not a significant change in the 
pulmonary function variables from baseline to 3 months (Wilk’s λ = 0.83, F (6,23) = 0.81, P > 
0.05, η2 = 0.17). 
 
Prediction of change in CF from baseline to 3 months from changes in aerobic fitness and 
from age. Results from the regression analysis indicated that the change in CF performance from 
baseline to 3 months could be reliably predicted from the change in V̇E (F (1,26) = 8.71, P < 
0.01, r2 = 0.25). Age was also a significant predictor and accounted for the explanation of an 
additional 12% of the variance (Fchange(1,25) = 4.81, P < 0.04). Thus, a decrease in the 
V̇E obtained at V̇O2peak and older age were predictive of greater improvement in CF performance. 
 
After 15 Additional Months of Exercise or of Normal Lifestyle 
 
Tests of changes from 3 months to 18 months. With regards to CF, neither the main effect for 
time (Wilk’s λ = 0.89, F (1,13) = 1.66, P > 0.05, η2 = 0.11) nor the main effect for group 
(F (1,13) = 2.08, P > 0.05, η2 = 0.14) was significant. The interaction of group by time was also 
not significant (Wilk’s λ = 0.86, F (1,13) = 2.08, P > 0.05, η2 = 0.14). Examination of the effect 
sizes for the groups indicated that there was essentially no change in CF from 3 months to 18 
months for the short-term group (ES = −0.03), whereas the long-term group had a moderate 
improvement in CF (ES = 0.47) from 3 months to 18 months. Furthermore, the ES for the 
comparison of CF performance at 18 months between the long-term group and the short-term 
group was 0.99, which indicated that the long-term group was performing better than the short-
term group at this time point. 
 
The main effect for time on walk distance was not significant (Wilk’s λ = 0.96, F (1,13) = 
0.61, P > 0.05, η2 = 0.05), nor was there a main effect for group (F (1,13) = 1.41, P > 0.05, η2 = 
0.10). However, there was a significant interaction effect for group by time (Wilk’s λ = 
0.67, F (1,13) = 6.52, P < 0.03, η2 = 0.33). The nature of this interaction was such that walk 
distance decreased from 3 months (mean = 1959.71, SD = 282.26) to 18 months (mean = 
1883.86, SD = 273.98) for the short-term group, whereas walk distance increased from 3 months 
(mean = 2041.50, SD = 202.34) to 18 months (mean = 2081.88, SD = 161.64) for the long-term 
group. 
 
A main effect for time was found for V̇O2peak (Wilk’s λ = 0.55, F (1,13) = 10.68, P < 0.01, η2 = 
0.45) and indicated that across groups, V̇O2peak decreased from 3 months (mean = 21.12, SD = 
3.77) to 18 months (mean = 19.85, SD = 3.81). However, there was not a significant effect for 
group (F (1,13) = 0.06, P > 0.05, η = 0.004), nor was there a significant interaction effect 
(Wilk’s λ = 0.91, F (1,13) = 1.34, P > 0.05, η2 = 0.09) for group by time. 
 
For the respiratory drugs taken, neither the main effect for time (Wilk’s λ = 0.97, F (1,13) = 
0.43, P > 0.05, η2 = 0.03), nor the main effect for group (F (1,13) = 3.39, P > 0.05, η2 = 0.21), 
nor the interaction of group by time (Wilk’s λ = 0.97, F (1,13) = 0.43, P > 0.05, η2 = 0.03) was 
significant. For the cardiovascular drugs taken, neither the main effect for time (Wilk’s λ = 
0.93, F (1,13) = 0.93, P > 0.05, η2 = 0.07), nor the main effect for group (F (1,13) = 1.13, P > 
0.05, η2 = 0.08), nor the interaction of group by time (Wilk’s λ = 1.00, F (1,13) = 0.004, P > 
0.05, η2 = 0.00) was significant. 
 
Neither the main effect of time (Wilk’s λ = 0.79, F (1,12) = 3.28, P > 0.05, η2 = 0.21), nor the 
main effect for group (F (1,12) = 0.39, P > 0.05, η2 = 0.03), nor the interaction of group by time 
(Wilk’s λ = 1.00, F (1,12) = 0.003, P > 0.05, η2 = 0.00) was significant for V̇E. 
 
For the SpO2 walk data, the main effect for time was significant (Wilk’s λ = 0.47, F (1,13) = 
14.75, P < 0.01, η2 = 0.53). Examination of the means for time indicated that both groups 
showed a slight decrease in SpO2 from 3 months (mean = 94.47, SD = 2.88) to 18 months (mean 
= 93.07, SD = 3.01). Neither the main effect for group (F (1,13) = 0.14, P > 0.05, η2 = 0.01) nor 
the interaction of group by time (Wilk’s λ = 0.91, F (1,13) = 1.33, P > 0.05, η2 = 0.09) was 
significant. For the GXT SpO2 data, neither the main effect for time (Wilk’s λ = 0.95, F (1,12) = 
0.69, P > 0.05, η2 = 0.05), nor the main effect for group (F (1,12) = 0.02, P > 0.05, η2 = 0.002), 
nor the interaction of group by time (Wilk’s λ = 0.98, F (1,12) = 0.28, P > 0.05, η2 = 0.02) was 
significant. 
 
Neither the main effect of time (Wilk’s λ = 0.65, F (6,8) = 0.72, P > 0.05, η2 = 0.35), nor the 
main effect for group (Wilk’s λ = 0.60, F (6,8) = 0.89, P > 0.05, η2 = 0.40), nor the interaction of 
group by time (Wilk’s λ = 0.30, F (6,8) = 3.16, P > 0.05, η2 = 0.70) was significant for the 
pulmonary function variables. 
 
 
Figure 1. Scatterplot of the change scores for Culture Fair (CF) and walk distance from 3 
months to 18 months as a function of exercise group. 
 
Prediction of change in CF from 3 months to 18 months from changes in aerobic 
fitness and from age and group. The regression analysis indicated that 57% of the variance in 
the change in CF from 3 months to 18 months could be reliably predicted (F (1,12) = 16.19, P < 
0.002) from the change in walk distance from 3 months to 18 months. The change in V̇E at 
V̇O2peak from 3 months to 18 months accounted for an additional 26% of the variance 
(Fchange(1,11) = 17.23, P < 0.002). Thus, the improvement in CF from 3 months to 18 months 
could be reliably predicted from the increase in walk distance (Fig. 1) and from the decrease in 
V̇E at V̇O2peak. 
 
DISCUSSION 
 
Before addressing the primary findings, it is worthwhile to mention that the exercise intervention 
in this study did not have a significant impact on depression as self-reported by the participants. 
That is, at 3 months, the decrease in depression from baseline was negligible (ES = 0.07) and 
nonsignificant. At 18 months, neither time, group, nor the interaction of time by group had a 
significant effect on self-reported depression and, again, the ESs were negligible. These findings 
were not anticipated, but are not remarkable in light of the low depression levels reported by the 
participants (see Table 2). 
 
The results with respect to cognitive performance at baseline indicated that depression, 
education, age, and aerobic fitness as assessed by a 6-min walk test are predictive of fluid 
intelligence. These findings replicate those reported previously with all REACT participants who 
completed baseline testing (20). This replication is not surprising, because these subjects are 
merely a subset of those included in the previous study; however, it is important because it 
suggests that the participants who agreed to participate in the longitudinal portion of the study 
are representative of those who agreed to only participate in baseline testing. 
 
Results at 3 months are also of interest because they replicate the findings of past research with 
relatively short-term exercise interventions (16,18,19). That is, results suggest that aerobic fitness, as 
assessed by V̇O2peak and walk distance, and cognitive functioning, as assessed by CF 
performance, increased significantly after participation in a 3-month exercise intervention. 
Results also indicated that the gain in CF performance from baseline to 3 months was reliably 
predicted by the decrease in V̇E at V̇O2peak from baseline to 3 months. Thus, the improvements in 
one of the measures of aerobic fitness were predictive of the improvements in cognitive 
performance. It is, however, important to qualify these results somewhat because of the fact that 
there was not a control group at this testing session and the comparison being made is a within-
subjects comparison relative to baseline measures. Thus, the results may only be interpreted to 
indicate an association between involvement in a 3-month exercise program and enhanced 
V̇O2peak, walk distance, and cognitive performance. It remains possible that the improvements in 
these variables are not caused by the exercise intervention itself, but rather are caused by 
confounding variables such as test reactivity, the social nature of the intervention, exposure to 3 
months of attention by health professionals, or a placebo effect. 
 
After 15 additional months of either continued participation in the exercise program or a 
departure from the formal exercise program, there was a further significant increase in walk 
distance for the long-term exercisers and a concomitant significant decrease in walk distance for 
the short-term exercisers. These results suggest that the long-term exercise intervention can 
result in increases in aerobic fitness (as assessed by walk distance) that exceed those obtained 
after the initial short-term exercise intervention. It is important to note that at this time point, a 
stronger case can be made for cause-and-effect because participants were randomly assigned to 
either the short-term or the long-term exercise intervention and the independent variable of 
exercise program duration was manipulated. 
 
Of further importance is the fact that the regression analysis indicated that increases in walk 
distance and decreases in V̇E at V̇O2peak from 3 months to 18 months are predictive of increases 
in CF performance from 3 months to 18 months. That is, participants who gained the most in 
terms of aerobic fitness (as assessed by both walk distance and the decrease in V̇E) also showed 
the biggest gains in CF performance. This is especially important when one considers that 83% 
of the variance in CF performance gain was predicted by the gain in walk distance and the 
decrease in V̇E at V̇O2peak. 
 
The interpretation of the results of this study is difficult for several reasons. The first difficulty is 
related to the fact that V̇O2peak did not continue to improve in the long-term exercise group as a 
result of the 15-month exercise intervention. This result is not surprising, however, given that a 
review of the literature has shown that exercise training in COPD patients has an inconsistent 
effect on V̇O2peak(6). The second difficulty in interpretation arises from the lack of a significant 
difference in cognitive functioning between the long-term and short-term groups at 18 months. 
However, we have acknowledged that our statistical power at this point is low and suggest that 
the effect sizes are actually indicative of meaningful changes in CF from 3 months to 18 months 
for the long-term group. That is, whereas the short-term group showed essentially no change, the 
long-term group showed a gain in CF performance from 3 months to 18 months that was equal to 
almost one half of a standard deviation. Furthermore, at 18 months the long-term exercise group 
was performing a full standard deviation better on the CF test than was the short-term group. 
Thus, the expected continued improvement in CF did occur for the long-term group and the 
expected maintenance of CF performance did occur in the short-term group, and statistical 
significance might have been reached had our sample size been larger. The third difficulty in 
interpretation arises from the fact that the group variable (short-term, long-term) did not obtain 
significance in the prediction equation at 18 months. Examination of Figure 1 provides an 
explanation for this, as there were two subjects in each group who did not exhibit the same 
pattern of change in walk distance or in CF as did the rest of their group. Thus, the results 
suggest that regardless of group assignment, those who gained the most in aerobic fitness (as 
assessed by walk distance and by V̇E) after 18 months were those who gained the most in 
cognitive performance. Although it is clear then that the exercise duration manipulation was 
somewhat effective at the group level (because the long-term group increased their average walk 
distance whereas the short-term group decreased their average walk distance), the results of the 
regression analysis suggest that at the individual level there may be other explanations for 
subsequent changes in cognition. 
 
One of these alternative explanations is that individual differences may be such that a person 
may be predisposed to gain the most aerobically (as assessed by the increase in walk distance 
and the decrease in V̇E at V̇O2peak) and to gain the most cognitively, and these individual 
differences may not be related to the exercise stimulus in a dose-response fashion. Another 
related explanation is that the initial formal exercise stimulus may have been sufficiently 
motivating, informative, and habit-forming that some of those previously sedentary COPD 
patients who were randomized to the short-term exercise group made lifestyle changes that 
impacted their subsequent performance on the CF test. Thus, the results suggest that although the 
ultimate increase in aerobic fitness (as assessed by walk distance and by V̇E at V̇O2peak) is 
predictive of cognitive gains, a long-term formal exercise program may not be required to realize 
these increases. Obviously, in terms of practical value this is an encouraging finding because it 
suggests that 3 months of formal exercise results in gains in cognitive performance for COPD 
patients. However, in terms of understanding the mechanisms underlying exercise-related 
differences and improvements in cognitive performance, our lack of success at clearly 
manipulating aerobic fitness after an 18-month exercise intervention limits our ability to pinpoint 
the mechanism. Future research should continue to examine aerobic fitness and cognition in 
search of the mechanisms that explain their relationship. 
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